| List Name |
Annotation |
Enrichment |
p-value |
| amino acid transport |
AmiGO Browser |
9.79 |
3.68e-03 |
| response to metal ion |
AmiGO Browser |
19.26 |
4.82e-03 |
| regulation of caspase activity |
AmiGO Browser |
8.09 |
6.26e-03 |
| amine transport |
AmiGO Browser |
7.68 |
7.22e-03 |
| response to inorganic substance |
AmiGO Browser |
14.98 |
7.90e-03 |
| response to chemical stimulus |
AmiGO Browser |
2.68 |
0.01 |
| organic acid transport |
AmiGO Browser |
6.26 |
0.01 |
| carboxylic acid transport |
AmiGO Browser |
6.26 |
0.01 |
| anti-apoptosis |
AmiGO Browser |
3.64 |
0.01 |
| death |
AmiGO Browser |
2.11 |
0.01 |
| cell death |
AmiGO Browser |
2.11 |
0.01 |
| mitotic checkpoint |
AmiGO Browser |
10.93 |
0.01 |
| electron transport |
AmiGO Browser |
2.87 |
0.02 |
| apoptosis |
AmiGO Browser |
2.06 |
0.02 |
| programmed cell death |
AmiGO Browser |
2.05 |
0.02 |
| oxygen and reactive oxygen species metabolic process |
AmiGO Browser |
5.01 |
0.02 |
| estrogen biosynthetic process |
AmiGO Browser |
33.71 |
0.03 |
| caspase activation |
AmiGO Browser |
7.49 |
0.03 |
| negative regulation of apoptosis |
AmiGO Browser |
2.93 |
0.03 |
| negative regulation of programmed cell death |
AmiGO Browser |
2.91 |
0.03 |
| positive regulation of caspase activity |
AmiGO Browser |
6.74 |
0.04 |
| regulation of interleukin-6 biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
| estrogen metabolic process |
AmiGO Browser |
25.28 |
0.04 |
| M phase |
AmiGO Browser |
2.70 |
0.04 |
| transition metal ion transport |
AmiGO Browser |
6.13 |
0.04 |
| transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
6.04 |
0.04 |
| regulation of apoptosis |
AmiGO Browser |
2.06 |
0.04 |
| cell development |
AmiGO Browser |
1.67 |
0.05 |
| regulation of programmed cell death |
AmiGO Browser |
2.04 |
0.05 |
| in utero embryonic development |
AmiGO Browser |
5.78 |
0.05 |
| copper ion transport |
AmiGO Browser |
20.23 |
0.05 |
| interleukin-6 biosynthetic process |
AmiGO Browser |
20.23 |
0.05 |
| interleukin-6 production |
AmiGO Browser |
20.23 |
0.05 |
| malate metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| G2/M transition checkpoint |
AmiGO Browser |
18.39 |
0.05 |
| zinc ion transport |
AmiGO Browser |
18.39 |
0.05 |
| G2/M transition DNA damage checkpoint |
AmiGO Browser |
18.39 |
0.05 |
| DNA ligation |
AmiGO Browser |
18.39 |
0.05 |
| male meiosis |
AmiGO Browser |
18.39 |
0.05 |
| negative regulation of protein kinase activity |
AmiGO Browser |
5.39 |
0.05 |
| negative regulation of transferase activity |
AmiGO Browser |
5.39 |
0.05 |
| mitosis |
AmiGO Browser |
2.85 |
0.05 |
| M phase of mitotic cell cycle |
AmiGO Browser |
2.79 |
0.06 |
| regulation of oxidoreductase activity |
AmiGO Browser |
16.86 |
0.06 |
| placenta development |
AmiGO Browser |
16.86 |
0.06 |
| protein deubiquitination |
AmiGO Browser |
15.56 |
0.06 |
| androgen metabolic process |
AmiGO Browser |
15.56 |
0.06 |
| mesoderm development |
AmiGO Browser |
4.93 |
0.06 |
| response to protein stimulus |
AmiGO Browser |
4.87 |
0.06 |
| response to unfolded protein |
AmiGO Browser |
4.87 |
0.06 |
| chromatin remodeling |
AmiGO Browser |
4.82 |
0.07 |
| mitotic spindle checkpoint |
AmiGO Browser |
14.45 |
0.07 |
| centrosome cycle |
AmiGO Browser |
14.45 |
0.07 |
| pyridine nucleotide biosynthetic process |
AmiGO Browser |
14.45 |
0.07 |
| sensory perception of pain |
AmiGO Browser |
13.48 |
0.07 |
| regulation of mitosis |
AmiGO Browser |
4.45 |
0.08 |
| regulation of chemotaxis |
AmiGO Browser |
12.64 |
0.08 |
| response to carbohydrate stimulus |
AmiGO Browser |
12.64 |
0.08 |
| ER-associated protein catabolic process |
AmiGO Browser |
12.64 |
0.08 |
| misfolded or incompletely synthesized protein catabolic process |
AmiGO Browser |
12.64 |
0.08 |
| spindle checkpoint |
AmiGO Browser |
11.90 |
0.08 |
| transcription from RNA polymerase I promoter |
AmiGO Browser |
11.90 |
0.08 |
| regulation of catalytic activity |
AmiGO Browser |
2.02 |
0.08 |
| acute inflammatory response |
AmiGO Browser |
4.21 |
0.08 |
| microtubule organizing center organization and biogenesis |
AmiGO Browser |
11.24 |
0.09 |
| centrosome organization and biogenesis |
AmiGO Browser |
11.24 |
0.09 |
| induction of apoptosis via death domain receptors |
AmiGO Browser |
11.24 |
0.09 |
| cell cycle phase |
AmiGO Browser |
2.13 |
0.09 |
| eye photoreceptor cell differentiation |
AmiGO Browser |
10.65 |
0.09 |
| dicarboxylic acid metabolic process |
AmiGO Browser |
10.65 |
0.09 |
| eye photoreceptor cell development |
AmiGO Browser |
10.65 |
0.09 |
| water-soluble vitamin biosynthetic process |
AmiGO Browser |
10.65 |
0.09 |
| dicarboxylic acid transport |
AmiGO Browser |
10.65 |
0.09 |
| traversing start control point of mitotic cell cycle |
AmiGO Browser |
10.65 |
0.09 |
| neutral amino acid transport |
AmiGO Browser |
10.65 |
0.09 |
| positive regulation of hydrolase activity |
AmiGO Browser |
3.97 |
0.09 |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
3.89 |
0.09 |
| photoreceptor cell development |
AmiGO Browser |
10.11 |
0.09 |
| photoreceptor cell differentiation |
AmiGO Browser |
10.11 |
0.09 |
| ubiquitin-dependent protein catabolic process |
AmiGO Browser |
2.77 |
0.10 |
| modification-dependent protein catabolic process |
AmiGO Browser |
2.76 |
0.10 |
| modification-dependent macromolecule catabolic process |
AmiGO Browser |
2.76 |
0.10 |
| proteolysis involved in cellular protein catabolic process |
AmiGO Browser |
2.73 |
0.10 |
| regulation of a molecular function |
AmiGO Browser |
1.91 |
0.10 |
| vitamin biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
| cellular protein catabolic process |
AmiGO Browser |
2.72 |
0.10 |
| release of cytochrome c from mitochondria |
AmiGO Browser |
9.19 |
0.10 |
| NADP metabolic process |
AmiGO Browser |
9.19 |
0.10 |
| cell structure disassembly during apoptosis |
AmiGO Browser |
9.19 |
0.10 |
| negative regulation of enzyme activity |
AmiGO Browser |
3.68 |
0.10 |
| generation of precursor metabolites and energy |
AmiGO Browser |
1.88 |
0.10 |
L2L Microarray Analysis Tool